NeuralStem

OverviewSuggest Edit

NeuralStem is a clinical-stage biopharmaceutical company. The Company's patented technology enables the commercial-scale production of multiple types of central nervous system stem cells, which are under development for the potential treatment of Ischemic Paraplegia, Traumatic Spinal Cord Injury, ALS and Parkinsona's Disease. NeuralStem's research has allowed them to produce mature, commercial quantities of neural stem cells that can be transplanted into humans as treatments for currently incurable diseases.

TypePublic
Founded1996
HQRockville, USMap
Websiteneuralstem.com
Employee Ratings2More

Locations

NeuralStem is headquartered in
Rockville, United States

Location Map
All Locations (1)

Latest Updates

Employees (est.) (Feb 2019)5(-54%)
Revenue (FY, 2017)$260 K(+1501%)
Share Price (Mar 2019)$0.5 (-3%)

Key People/Management at NeuralStem

James B. Scully

James B. Scully

Interim CEO & PAO
Karl Johe

Karl Johe

CSO
David Recker

David Recker

CMO
Thomas Hazel

Thomas Hazel

Senior Vice President, Research
Show more

NeuralStem Office Locations

NeuralStem has an office in Rockville
Rockville, US (HQ)
9700 Great Seneca Hwy
Show all (1)
Report incorrect company information

NeuralStem Financials and Metrics

NeuralStem Revenue

NeuralStem's revenue was reported to be $260 k in FY, 2017
USD

Revenue (Q2, 2018)

252.5k

Net income (Q2, 2018)

(627.0k)

EBIT (Q2, 2018)

(2.0m)

Market capitalization (13-Mar-2019)

9.3m

Closing stock price (13-Mar-2019)

0.5

Cash (30-Jun-2018)

7.1m
NeuralStem's current market capitalization is $9.3 m.
Annual
USDFY, 2013FY, 2015FY, 2016FY, 2017

Revenue

110.0k10.4k16.2k260.0k

General and administrative expense

5.3m6.5m7.5m5.5m

Operating expense total

12.6m19.2m20.7m13.6m

Depreciation and amortization

244.7k
Quarterly
USDQ3, 2013Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Revenue

2.5k5.0k5.0k2.9k2.5k2.5k2.5k2.5k2.5k2.5k2.5k2.5k252.5k

General and administrative expense

1.7m1.5m2.0m1.4m1.7m1.8m3.2m1.4m1.3m1.6m1.2m1.2m1.3m

R&D expense

1.9m2.1m3.2m3.3m3.4m3.1m2.5m3.6m2.6m1.4m1.2m1.0m

Operating expense total

3.6m3.5m4.0m4.6m5.0m5.2m6.2m3.8m4.9m4.2m2.6m2.4m2.3m
show all
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

16.8m12.5m4.7m15.2m6.7m

Accounts Receivable

Inventories

Current Assets

17.6m28.2m13.5m20.9m12.4m
Quarterly
USDQ3, 2013Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Cash

16.4m15.2m11.9m13.6m8.6m13.1m7.6m11.1m5.7m6.4m9.1m9.7m7.1m

Current Assets

17.3m30.8m27.7m29.2m24.7m19.6m8.7m11.8m6.7m11.7m14.7m10.2m7.9m

PP&E

253.6k310.1k301.3k282.1k343.0k335.9k337.0k363.2k315.5k219.4k196.2k149.7k128.0k

Total Assets

19.2m32.6m29.4m30.8m26.4m21.1m10.2m13.3m8.5m13.3m16.2m11.5m9.2m
show all
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(19.8m)(22.6m)(20.9m)(21.1m)(15.7m)

Depreciation and Amortization

244.7k348.6k345.5k337.5k289.2k

Inventories

Accounts Payable

(116.7k)1.4m(1.0m)879.1k(1.5m)
Quarterly
USDQ3, 2013Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Net Income

(16.5m)(12.7m)(4.5m)(5.1m)(10.5m)(16.1m)(6.6m)(10.5m)(15.7m)(12.2m)(12.4m)(2.1m)(2.8m)

Depreciation and Amortization

182.0k177.2k83.0k167.4k255.4k85.5k177.5k275.1k180.6k233.6k67.4k114.3k

Accounts Payable

(97.1k)465.6k2.4m2.1m(405.1k)(1.3m)1.2m955.2k1.0m(160.7k)(920.6k)293.1k(151.7k)

Cash From Operating Activities

(8.1m)(5.1m)(9.5m)(15.0m)(3.5m)(7.1m)(11.5m)(7.8m)(11.1m)(1.8m)(4.4m)
show all
USDY, 2018

Financial Leverage

1.5 x
Show all financial metrics
Report incorrect company information

Competitors

InVivo Therapeutics
Healthcare - Public
Immunic
Healthcare - Private
IO Biotech
Healthcare - Private
Breath Therapeutics
Healthcare - Private
Compare competitors

NeuralStem Online and Social Media Presence

Embed Graph
Report incorrect company information

 NeuralStem Frequently Asked Questions

  • When was NeuralStem founded?

    NeuralStem was founded in 1996.

  • Who are NeuralStem key executives?

    NeuralStem's key executives are James B. Scully, Karl Johe and David Recker.

  • How many employees does NeuralStem have?

    NeuralStem has 5 employees.

  • What is NeuralStem revenue?

    Latest NeuralStem annual revenue is $260 k.

  • What is NeuralStem revenue per employee?

    Latest NeuralStem revenue per employee is $52 k.

  • Who are NeuralStem competitors?

    Competitors of NeuralStem include InVivo Therapeutics, Immunic and IO Biotech.

  • Where is NeuralStem headquarters?

    NeuralStem headquarters is located at 9700 Great Seneca Hwy, Rockville.

  • Where are NeuralStem offices?

    NeuralStem has an office in Rockville.

  • How many offices does NeuralStem have?

    NeuralStem has 1 office.